134 related articles for article (PubMed ID: 37458482)
1. The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study.
Saraiva L; Cunha RN; Jesus D; Gatto M; Zen M; Iaccarino L; da Silva JAP; Doria A; Inês LS
Rheumatology (Oxford); 2024 Apr; 63(4):1123-1129. PubMed ID: 37458482
[TBL] [Abstract][Full Text] [Related]
2. Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up.
Cunha RN; Saraiva L; Jesus D; Doria A; da Silva JP; Inês LS
Rheumatology (Oxford); 2023 Nov; 62(11):3627-3635. PubMed ID: 36847423
[TBL] [Abstract][Full Text] [Related]
3. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
Thanou A; Chakravarty E; James JA; Merrill JT
Rheumatology (Oxford); 2014 Dec; 53(12):2175-81. PubMed ID: 24729400
[TBL] [Abstract][Full Text] [Related]
4. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
[TBL] [Abstract][Full Text] [Related]
5. Predicting flares in patients with stable systemic lupus erythematosus.
Cho J; Lahiri M; Teoh LK; Dhanasekaran P; Cheung PP; Lateef A
Semin Arthritis Rheum; 2019 Aug; 49(1):91-97. PubMed ID: 30660381
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.
FitzGerald JD; Grossman JM
Lupus; 1999; 8(8):638-44. PubMed ID: 10568901
[TBL] [Abstract][Full Text] [Related]
7. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
8. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
[TBL] [Abstract][Full Text] [Related]
9. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
10. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
[TBL] [Abstract][Full Text] [Related]
11. SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy.
Larosa M; Costedoat-Chalumeau N; Guettrot-Imbert G; Le Guern V; Morel N; Jesus D; Iaccarino L; Inês L; Doria A
Front Pharmacol; 2021; 12():660123. PubMed ID: 33935783
[No Abstract] [Full Text] [Related]
12. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA.
Isenberg DA; Allen E; Farewell V; D'Cruz D; Alarcón GS; Aranow C; Bruce IN; Dooley MA; Fortin PR; Ginzler EM; Gladman DD; Hanly JG; Inanc M; Kalunian K; Khamashta M; Merrill JT; Nived O; Petri M; Ramsey-Goldman R; Sturfelt G; Urowitz M; Wallace DJ; Gordon C; Rahman A
Ann Rheum Dis; 2011 Jan; 70(1):54-9. PubMed ID: 20833737
[TBL] [Abstract][Full Text] [Related]
13. Pathways of impending disease flare in African-American systemic lupus erythematosus patients.
Munroe ME; Vista ES; Merrill JT; Guthridge JM; Roberts VC; James JA
J Autoimmun; 2017 Mar; 78():70-78. PubMed ID: 28162788
[TBL] [Abstract][Full Text] [Related]
14. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
15. Impact of teleconsultation on subsequent disease activity and flares in patients with systemic lupus erythematosus.
Au Eong JTW; Lateef A; Liang S; Lim SHH; Tay SH; Mak A; Cho J
Rheumatology (Oxford); 2022 May; 61(5):1911-1918. PubMed ID: 34554232
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity.
Sun F; Zhao L; Wang H; Zhang D; Chen J; Wang X; Li T; Ye S
Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35606018
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of flares during pregnancy and post-partum in stable lupus patients.
Davis-Porada J; Kim MY; Guerra MM; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Sawitzke A; Merrill JT; Buyon JP; Salmon JE
Arthritis Res Ther; 2020 Mar; 22(1):52. PubMed ID: 32188491
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio reflect disease activity and flares in patients with systemic lupus erythematosus - A prospective study.
Cho J; Liang S; Lim SHH; Lateef A; Tay SH; Mak A
Joint Bone Spine; 2022 Jul; 89(4):105342. PubMed ID: 35032639
[TBL] [Abstract][Full Text] [Related]
19. The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study.
Bae SC; Bass DL; Chu M; Curtis P; Dimelow R; Harvey L; Ji B; Kurrasch R; Muzaffar S; Punwaney R; Roth DA; Song YW; Xie W; Zhang F
Arthritis Res Ther; 2022 Feb; 24(1):46. PubMed ID: 35172878
[TBL] [Abstract][Full Text] [Related]
20. A surge in anti-dsDNA titer predicts a severe lupus flare within six months.
Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA
Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
